Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.99−0.02 (-1.00%)
Close on Nov 12, 2026Market cap $73.19MP/E –Yield –
Fortress Biotech ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Fortress Biotech's ebitda for the twelve months ending Mar 31, 2017 was -$83.94M. For fiscal 2017 it was -$88.63M. The highest annual figure on record is -$20.63M in fiscal 2014.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -$88.63M | – |
| FY2016 | Dec 31, 2016 | -$64.77M | – |
| FY2015 | Dec 31, 2015 | -$50.51M | – |
| FY2014 | Dec 31, 2014 | -$20.63M | – |
| FY2013 | Dec 31, 2013 | -$35.76M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2017 | Mar 31, 2017 | -$18.44M | – |
| Q4 FY2016 | Dec 31, 2016 | -$31.51M | – |
| Q3 FY2016 | Sep 30, 2016 | -$17.01M | – |
See a number that looks wrong?